Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Sarcoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Neoplasms 2Inflammatory Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Ovarian Neoplasms 1Osteosarcoma 1Neutropenia 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Bile Duct Neoplasms 1

Interventions

Filgrastim 5Docetaxel 3Carboplatin 3Cyclosporine 2Cyclophosphamide 2sargramostim 1pegfilgrastim 1ixabepilone 1flt3 ligand protein 1eflapegrastim 1Topotecan 1Thrombopoietin 1Taxes 1Stem Cell Factor 1Phenobarbital 1Paclitaxel 1Oxaliplatin 1Mannose-Binding Lectin 1Leucovorin 1Lenalidomide 1Irinotecan 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Etoposide 1Epoetin Alfa 1Epirubicin 1EC regimen 1Doxorubicin 1Diet, High-Fat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neutropenia × Epirubicin × Clear all
NCT00002866 2020-04-01

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1 Completed
50 enrolled
Breast

Breast Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡